Symrise stock: fair value
SY1.DEThe fair value of Symrise under our model is $77.44, the price is 39% above.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $55.32 and expensive above $129.07 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $106.70 (cash-flow model) and $48.19 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 7.1%. At 8.1% the fair value would be $68.34, at 6.1% it would be $91.11.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 2.1%. Discounted at 7.1% (floor: government bond yield 2.1% plus 5 percentage points, since beta 0.93 times the risk premium would give less); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $106.70 per share: free cash flow for the next ten years, each year discounted to today at 7.1%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 7.1%) |
|---|---|---|---|---|
| 2026 | $606.76M | extrapolated at 12.6% | 0.9334 | $566.32M |
| 2027 | $664.11M | extrapolated at 9.5% | 0.8712 | $578.54M |
| 2028 | $712.31M | extrapolated at 7.3% | 0.8131 | $579.18M |
| 2029 | $753.08M | extrapolated at 5.7% | 0.7589 | $571.52M |
| 2030 | $788.08M | extrapolated at 4.7% | 0.7083 | $558.23M |
| 2031 | $818.78M | extrapolated at 3.9% | 0.6611 | $541.32M |
| 2032 | $846.36M | extrapolated at 3.4% | 0.6171 | $522.27M |
| 2033 | $871.76M | extrapolated at 3.0% | 0.5760 | $502.09M |
| 2034 | $895.66M | extrapolated at 2.7% | 0.5376 | $481.48M |
| 2035 | $918.6M | extrapolated at 2.6% | 0.5017 | $460.91M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $5.36B |
| Terminal value: cash flow 2035 × (1 + 2.1%) / (7.1% − 2.1%) | $18.77B |
| Present value of terminal value (× 0.5017) | $9.42B |
| Equity value (sum plus present value of terminal value) | $14.78B |
| Shares (diluted) | 138.49M |
| Value per share (equity value divided by shares) | $106.70 |
| Earnings per share, last twelve months | $1.97 |
| × 24.4 (industry P/E) | $48.19 |
| Fair value (average of both parts) | $77.44 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jul 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.